With COVID now added to the annual mix of viruses that typically circulate every year, including influenza, respiratory syncytial virus (RSV), and other respiratory viruses, “sick season” is likely to be worse—and longer—going forward.
Although COVID cases have ticked up, there is also good news: Old COVID tests may still be good; businesses should know how to pivot if infections keep climbing; and overall COVID conditions aren't nearly as bad as they…
The U.S. response to the COVID-19 pandemic was full of missteps—ones that experts say can inform preparations for future global health emergencies.
Bill Hanage discusses the current state of the monkeypox outbreak and efforts to control disease spread.
Screening programs at Boston-area universities helped show how quickly the Omicron variant of the coronavirus overtook the Delta variant in the fall of 2021, according to a new study.
For immediate release: February 2, 2022 Boston, MA – The SARS-CoV-2 Omicron variant’s “milder” outcomes are likely due to more population immunity compared to earlier waves of the pandemic rather than the virus’s properties, according to a paper…
Delta-like SARS-CoV-2 variants are most likely to increase pandemic severity, according to a new study.
Cloth masks are widely used in the U.S., but some experts say surgical masks could offer better protection against COVID-19.
As variants of SARS-CoV-2 continue to emerge and spread among both vaccinated and unvaccinated people, epidemiologists are finding it increasingly difficult to predict how the virus might evolve and continue to spread, according to a September 15, 2021,…
The Delta variant of the coronavirus has been spreading rapidly throughout the U.S. and worldwide. Epidemiologist William Hanage discusses the threat.